Harry Erba

Professor of Medicine
Harry Erba

Overview

I am a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine.  I serve as Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies.  I am also the Chair of the SWOG Leukemia Committee.  I am interested in the clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia.  Specifically, I have been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy.  

Positions

Professor of Medicine in the School of Medicine

2023 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2018 School of Medicine

Education

M.D. 1988

1988 Stanford University, School of Medicine

Ph.D. 1988

1988 Stanford University

Residency Physician, Medicine

1990 Brigham and Women's Hospital

Clinical Fellow in Medicine, Medicine

1991 Harvard Medical School

Research/Clinical Fellowship in Medicine, Medicine

1992 Brigham and Women's Hospital

Research Fellowship in Medicine, Medicine

1993 Harvard Medical School

Clinical Trials

View All

Publications, Grants & Awards

DCI Centers, Cancer Types & Labs

Offices & Contact

2400 Pratt St Suite 5000, DUMC Box 3961
Durham, NC
27710
DUMC Box 3961
Durham, NC
27710